Catalytic antibodies are disclosed. The catalytic antibodies are specific for prodrug compounds. The catalytic antibodies enhance cleavage of an active drug moiety from a prodrug residue, thereby activating the drug....http://www.google.com/patents/US6702705?utm_source=gb-gplus-sharePatent US6702705 - Prodrugs activated by targeted catalytic proteins
